1. LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding
- Author
-
Mikolaj Slabicki, Katja Blumenstock, Per Hoffmann, Marius Jentzsch, Thomas S. Ebert, Maximilian Schmitz, Ofir Israeli, Markus M. Nöthen, Gero Wilbring, Manuel Döhla, Nina Ishorst, Julia Reinhardt, David Li, Nir Paran, Max L. Jacobs, Ines H. Kaltheuner, Eva C. Beins, Jonathan Strecker, Feng Zhang, Amir Ben-Shmuel, Ricarda Maria Schmithausen, Bärbel Lippke, David Feldman, Aliona Wöhler, Martin Exner, Esther Sib, Aviv Regev, Jana Liebing, Matthias Geyer, Brian Cleary, Jonathan L. Schmid-Burgk, Kerstin U. Ludwig, Ronja Hollstein, Wibke Rüdiger, Rhiannon K. Macrae, Shay Weiss, Jacob Borrajo, Lara M. Hochfeld, and Michael Hölzel
- Subjects
Detection limit ,0303 health sciences ,Cycle threshold ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Biomedical Engineering ,Large population ,Loop-mediated isothermal amplification ,Bioengineering ,Computational biology ,Biology ,Applied Microbiology and Biotechnology ,Multiplexing ,03 medical and health sciences ,0302 clinical medicine ,Molecular Medicine ,030217 neurology & neurosurgery ,030304 developmental biology ,Biotechnology - Abstract
Frequent testing of large population groups combined with contact tracing and isolation measures will be crucial for containing Coronavirus Disease 2019 outbreaks. Here we present LAMP-Seq, a modified, highly scalable reverse transcription loop-mediated isothermal amplification (RT-LAMP) method. Unpurified biosamples are barcoded and amplified in a single heat step, and pooled products are analyzed en masse by sequencing. Using commercial reagents, LAMP-Seq has a limit of detection of ~2.2 molecules per µl at 95% confidence and near-perfect specificity for severe acute respiratory syndrome coronavirus 2 given its sequence readout. Clinical validation of an open-source protocol with 676 swab samples, 98 of which were deemed positive by standard RT-qPCR, demonstrated 100% sensitivity in individuals with cycle threshold values of up to 33 and a specificity of 99.7%, at a very low material cost. With a time-to-result of fewer than 24 h, low cost and little new infrastructure requirement, LAMP-Seq can be readily deployed for frequent testing as part of an integrated public health surveillance program.
- Published
- 2021
- Full Text
- View/download PDF